Evusheld, a course of injected antibodies, helps protect people with weak immune systems for up to six months. The government is making it available through pharmacies and individual providers.
The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck says it will have 10 million packs available by the end of the month.
If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.
Jennifer Minhas is among those who suffer lingering problems after COVID-19. A diagnosis of POTS, a little-known circulation disorder that mostly affects women, offers a way forward.
Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.
Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.
Antibody-based drugs that bind to the coronavirus to prevent it from invading cells can help patients with mild to moderate COVID-19. But the medicines can be tough to find in time.
More than 250,000 courses of convalescent plasma have been administered to Americans to help prevent severe consequences from COVID-19. Yet, health care professionals urgently need a steady, reliable supply of plasma.
Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation problems are two of the reasons.
A new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses SARS-CoV-2 transmission in some animals within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.
More hospitalized patients are surviving than early in the pandemic. Improved treatments make a big difference, but so does flattening the curve to keep hospitals from overfilling, researchers say.
